LinkedIn
Facebook
Visit Website
Quotient provides individual or integrated, end-to-end CRO and CDMO services to pharma and biotech companies worldwide, helping to accelerate drug development.
Quotient Sciences B2B Case Studies & Customer Successes
Case Studies
Showing 11 Quotient Sciences Customer Success Stories
BioCryst Pharmaceuticals accelerates BCX4161 development with Quotient Sciences Translational Pharmaceutics
BioCryst Pharmaceuticals
Clovis Oncology accelerates optimized salt formulation development with Quotient Sciences’ Translational Pharmaceutics®
Clovis Oncology
Compass Pathways advances COMP360 development with Quotient Sciences human ADME study
Compass Pathways
Corcept Therapeutics accelerates first-in-human drug development with Quotient Sciences
Corcept Therapeutics
Endevica Bio accelerates peptide drug development with Quotient Sciences' Translational Pharmaceutics
Endevica Bio
Ensysce Biosciences achieves faster modified release formulation development with Quotient Sciences' Translational Pharmaceutics
Ensysce Biosciences
MEI Pharma accelerates cancer therapy development with Quotient Sciences Translational Pharmaceutics
MEI Pharma
Pulmatrix accelerates Phase I inhaled drug development with Quotient Sciences
Pulmatrix
a UK-based specialty pharma company validates a non-haem iron assay with Quotient Sciences
UK-based Specialty Pharma Company
a US biopharmaceutical company achieves drug substance and salt selection with Quotient Sciences
US Biopharmaceutical Company
Xspray Pharma improves bioavailability and reduces food interactions with Quotient Sciences Translational Pharmaceutics
Xspray Pharma
No matching case studies
